Reaching European attendees, our 2025 Post-ESMO report sought to understand the event’s areas of greatest interest. 100 European oncologists and hematologist-oncologists shared with us the findings and developments they found most exciting.
Learn what respondents thought of the latest advancements including Immunotherapies, breast cancer, and Urothelial cancer treatments.
Download the report today.